FILOSTO, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 11.252
AS - Asia 6.563
EU - Europa 3.256
SA - Sud America 1.507
Continente sconosciuto - Info sul continente non disponibili 349
AF - Africa 145
OC - Oceania 8
Totale 23.080
Nazione #
US - Stati Uniti d'America 10.972
SG - Singapore 2.637
CN - Cina 1.370
BR - Brasile 1.279
HK - Hong Kong 967
IT - Italia 596
VN - Vietnam 457
BD - Bangladesh 374
UA - Ucraina 357
DE - Germania 328
FR - Francia 312
GB - Regno Unito 305
PL - Polonia 290
FI - Finlandia 276
RU - Federazione Russa 269
TR - Turchia 261
IE - Irlanda 220
IN - India 136
CA - Canada 130
AR - Argentina 84
MX - Messico 78
SE - Svezia 67
IQ - Iraq 64
ZA - Sudafrica 61
NL - Olanda 53
AT - Austria 49
JP - Giappone 48
ID - Indonesia 37
PK - Pakistan 32
ES - Italia 31
EC - Ecuador 29
UZ - Uzbekistan 28
PY - Paraguay 27
CZ - Repubblica Ceca 25
VE - Venezuela 22
CL - Cile 21
CO - Colombia 20
SA - Arabia Saudita 20
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
EG - Egitto 16
IL - Israele 16
LT - Lituania 14
JM - Giamaica 13
KE - Kenya 13
MA - Marocco 12
UY - Uruguay 12
CR - Costa Rica 11
PE - Perù 11
JO - Giordania 10
NP - Nepal 10
TW - Taiwan 10
TN - Tunisia 9
BE - Belgio 8
GR - Grecia 8
NG - Nigeria 8
PH - Filippine 8
LB - Libano 7
AU - Australia 6
AZ - Azerbaigian 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GT - Guatemala 6
HN - Honduras 6
OM - Oman 6
PA - Panama 6
AL - Albania 5
KZ - Kazakistan 5
PT - Portogallo 5
SN - Senegal 5
DZ - Algeria 4
GE - Georgia 4
IR - Iran 4
MU - Mauritius 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BY - Bielorussia 3
EU - Europa 3
KH - Cambogia 3
LV - Lettonia 3
PR - Porto Rico 3
RO - Romania 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
KR - Corea 2
MD - Moldavia 2
MM - Myanmar 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
Totale 22.716
Città #
Fairfield 1.312
Singapore 1.280
Ashburn 1.172
Hong Kong 965
Woodbridge 685
Seattle 606
Houston 548
The Dalles 481
San Jose 455
Wilmington 453
Cambridge 432
Princeton 405
New York 336
Warsaw 287
Jacksonville 279
Lauterbourg 251
Beijing 247
Council Bluffs 246
Los Angeles 246
Istanbul 222
Dublin 216
Ann Arbor 214
Helsinki 191
Chandler 151
Dallas 145
Ho Chi Minh City 145
Des Moines 136
Buffalo 117
Moscow 113
Redondo Beach 104
Columbus 99
Santa Clara 95
San Diego 94
São Paulo 93
Hanoi 91
Munich 83
Brescia 80
London 80
Chicago 63
Shanghai 61
Milan 55
Nanjing 51
Nuremberg 47
San Francisco 47
Boardman 44
Atlanta 43
Rio de Janeiro 43
Tokyo 41
Turku 40
Brooklyn 39
Montreal 38
Orem 37
Rome 32
Johannesburg 31
Denver 30
Phoenix 30
Toronto 30
Lappeenranta 28
Frankfurt am Main 27
Guangzhou 27
Porto Alegre 27
Tashkent 27
Belo Horizonte 26
Pune 25
Vienna 25
Baghdad 23
Chennai 23
Naples 23
Romola 23
Dearborn 22
Dhaka 22
Mexico City 22
Poplar 22
Curitiba 20
Da Nang 20
Manchester 20
Stockholm 20
Tianjin 20
Brasília 19
Boston 18
Changsha 18
Norwalk 18
Amsterdam 16
Nanchang 16
Charlotte 15
Goiânia 15
Haiphong 15
Jinan 15
Salt Lake City 15
Shenyang 15
Guarulhos 14
Guayaquil 14
New Delhi 14
Washington 13
Cape Town 12
Dong Ket 12
Lancaster 12
Tampa 12
Thái Nguyên 12
Biên Hòa 11
Totale 14.770
Nome #
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 357
Very late-onset friedreich ataxia with laryngeal dystonia 318
A Novel Mutation in the Stalk Domain of KIF5A Causes a Slowly Progressive Atypical Motor Syndrome 267
COVID-19 impact on consecutive neurological patients admitted to the emergency department 266
A complex craniovertebral junction malformation in a patient with late onset glycogenosis 2 255
Critical illness myopathy 249
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 208
A high-dose bortezomib neuropathy with sensory ataxia and myelin involvement. 192
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 188
A new mutation in the mitochondrial tRNAAla gene in a patient with ophthalmoplegia and dysphagia 175
Gold Coast Criteria in ALS Diagnosis: A Real-World Experience 171
A novel mitochondrial tRNA(Ala) gene variant causes chronic progressive external ophthalmoplegia in a patient with Huntington disease. 169
Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy 168
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 167
Small nerve fiber pathology in critical illness 166
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 164
Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype-phenotype studies 157
A novel CAPN1 mutation causes a pure hereditary spastic paraplegia in an Italian family 154
Coffee and amyotrophic lateral sclerosis: A possible preventive role 149
Autosomal recessive Bethlem myopathy: A clinical, genetic and functional study 144
Snake-Eye Myelopathy and Surgical Prognosis: Case Series and Systematic Literature Review 142
Mitochondrial DNA-related disorders. 132
Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II 132
The brain in late-onset glycogenosis II: a structural and functional MRI study. 132
Analysis of C9Orf72 Expansions in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: Preliminary Data 130
Novel mitochondrial tRNALeu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 130
Neuropathology of mitochondrial diseases. 129
C9orf72 Intermediate Repeats Confer Genetic Risk for Severe COVID-19 Pneumonia Independently of Age 128
Muscle pain in mitochondrial diseases: a picture from the Italian network 126
Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study 125
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 125
MR Neurography in Diagnosing Nondiabetic Lumbosacral Radiculoplexus Neuropathy 124
Poor Outcome in a Mitochondrial Neurogastrointestinal Encephalomyopathy Patient with a NovelTYMPMutation: The Need for Early Diagnosis 122
Exploring Olfactory Function and Its Relation with Behavioral and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients: A Cross-Sectional Study. 121
Editorial: Iron and Neurodegeneration 121
Human leukocyte antigens class II in CIDP spectrum neuropathies 119
SELENON-related myopathy as a cause of acute respiratory failure in middle age: a case report 114
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD) 114
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group 113
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 110
Impact of environmental factors and physical activity on disability and quality of life in CIDP 110
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial) 110
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 110
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE-MTDPS1) 109
Magnetic resonance imaging of the peripheral nerve 108
Psychosocial impact of sport activity in neuromuscular disorders 107
Late and severe myopathy in a patient with glycogenosis VII worsened by cyclosporin and amiodarone 106
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: Report of a family 105
Primary mitochondrial myopathy: 12-month follow-up results of an Italian cohort 104
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 103
Advances in quantitative imaging of genetic and acquired myopathies: Clinical applications and perspectives 103
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis 102
Vaccination recommendations for patients with neuromuscular disease 102
On the Comparison of Markov Chains-based Models in Process Mining for Healthcare: A Case Study 101
A 5-year clinical follow-up study from the Italian National Registry for FSHD 99
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis 99
Muscle biopsy displaying "double trouble" pathology: Combined features of periodic paralysis and dermatomyositis 99
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 98
Clinical spectrum and evolution of monoclonal gammopathy-associated neuropathy: An observational study 98
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 98
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia 97
Alterazioni delle fibre sensitive di piccolo calibro intra-epidermiche in pazienti con critical illness myopathy and neuropathy. Dati preliminari. 96
A mobile app for patients with Pompe disease and its possible clinical applications 96
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years 96
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: A simple test to identify this condition 94
Juvenile-Onset Recurrent Rhabdomyolysis Due to Compound Heterozygote Variants in the ACADVL Gene 93
Prevalence of asymptomatic vertebral fractures in late-onset pompe disease 93
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1) 93
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 92
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy 92
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 92
A Comprehensive Update on Late-Onset Pompe Disease 91
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 91
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 91
Late-onset glycogen storage disease type 2 89
Extensive digital health technology assessment detects subtle motor impairment in mild and asymptomatic Pompe disease 88
Lipomatosis incidence and characteristics in an Italian cohort of mitochondrial patients 88
ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: A clinical, biochemical and molecular study 88
Strategies for treating mitochondrial disorders: An update 88
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy 88
The role of mitochondria in neurodegenerative diseases 87
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genome 87
The genetic basis of undiagnosed muscular dystrophies and myopathies 87
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 86
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 86
A novel mutation in motor domain of KIF5A associated with an HSP/axonal neuropathy phenotype 86
RELEVANCE OF DIAGNOSTIC INVESTIGATIONS IN CHRONIC INFLAMMATORY DEMYELINATING POLIRADICULONEUROPATHY: DATA FROM THE ITALIAN CIDP DATABASE 85
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 84
Mitochondrial diseases: Advances and issues 83
A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody 83
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy 82
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1c 82
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 81
Progress in enzyme replacement therapy in glycogen storage disease type II 81
Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis? 81
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 81
Imaging of the muscle 80
Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy 79
Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis 79
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 78
Totale 12.138
Categoria #
all - tutte 149.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 149.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.198 0 293 25 39 11 81 137 91 85 57 115 264
2022/2023860 223 22 22 21 50 266 3 53 103 13 36 48
2023/20241.565 61 29 146 57 56 267 47 45 487 27 38 305
2024/20253.934 28 11 48 503 459 322 268 87 550 360 775 523
2025/20269.042 731 1.283 719 1.287 716 497 1.179 439 504 792 518 377
2026/2027727 431 296 0 0 0 0 0 0 0 0 0 0
Totale 23.080